Senate votes to fund Trump administration to fight opioid epidemic
The Senate has passed a bill that would fund President Donald Trump’s administration to combat the opioid epidemic and allow states to set their own priorities for tackling the epidemic, but only if there are no other short-term federal grants to do so.
The bill, H.R. 3801, by Sen. Tom Coburn, R-Okla., and Sen. Ron Johnson, R.W. (R-Wis.), would provide $50 million to the Office of National Drug Control Policy (ONDCP), which oversees drug control.
It also provides $30 million for the National Institute on Drug Abuse (NIDA), the federal agency that funds and funds the National Institutes of Health, the Centers for Disease Control and Prevention, and the National Science Foundation.
The two provisions are in line with the Senate bill, which passed the House by a wide margin in June and has since been sent to Trump’s desk.
The House bill, known as the Pain Control, Recovery, and Access Act, included the NIDA funds, which expired at the end of June.
The Senate bill includes the NPDAP funds, but the provisions expire in 2027, and Coburn said he is hopeful that lawmakers will work out a longer-term solution.
In an interview, Coburn was optimistic that Congress would come to an agreement to extend NIDA’s funding.
“If we can get that money back to the states, it will help our country recover from the opioid crisis,” Coburn told reporters.
“If we are able to find a way to extend that money for 10 years, I would certainly support that.”
“I think that is something we should do.
I would be a bit more hopeful if we could get that funding back to states.
But I am hopeful that Congress will get that done, because we are facing a crisis of this magnitude right now,” he added.
Coburn said that he and Johnson hope to see an agreement by the end and that “we can get some relief in the form of the NODAP funding.”
But he said that the bill was not yet done.
“We are still negotiating with the administration on this issue.
So, it is not ready to go to the floor for a vote.
But we are trying to get some help to help states.
And the more help we can give, the better it will be for our country,” Cobansaid.
Cobyresaid that there was a lot of uncertainty about whether the Senate would approve the bill.
“What is a deal if the president is not willing to work with Congress?” he asked.
“So I don’t know what it is.
I am hoping that we can make progress on this in the coming days.
I hope we will get it passed.”
A spokesman for Johnson said the president supports the NIDAP funds.
“It’s good news that the House is taking action to address the opioid pandemic, and President Johnson believes Congress should do so as well,” the statement said.
“The president has said that Congress must be given a chance to pass legislation to provide funding to address this crisis.
He has also pledged to veto any legislation that does not provide adequate relief to states.”